replace
Triage: Uncategorized /resultsSection/adverseEventsModule/frequencyThreshold Before
4
After
0
NCT05243641
Version 14 to 15 · M.D. Anderson Cancer Center
Patch inspector
Manual review pending.
adverse_event_group_changeother_adverse_event_additionother_adverse_event_modificationserious_adverse_event_additionserious_adverse_event_modification None recorded.
910374f683b05bf8b3a2a30ccfebf33abf05c42ae71774869d31b68c8f08decd/resultsSection/adverseEventsModule/frequencyThreshold 4
0
/resultsSection/adverseEventsModule/eventGroups/0/title adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. Phase Ib
Phase Ib: Dose Level 1
/resultsSection/adverseEventsModule/eventGroups/0/description adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. Dose Escalation of Neratinib with Capmatinib uses a 3+3 design. Max 18 patients, treated in cohorts of 3, with safety data reviewed after each cohort's DLT period.
Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 400 mg twice daily
/resultsSection/adverseEventsModule/eventGroups/0/deathsNumAffected adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. 1
0
/resultsSection/adverseEventsModule/eventGroups/0/deathsNumAtRisk adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. 10
7
/resultsSection/adverseEventsModule/eventGroups/0/seriousNumAffected adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. 2
1
/resultsSection/adverseEventsModule/eventGroups/0/seriousNumAtRisk adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. 10
7
/resultsSection/adverseEventsModule/eventGroups/0/otherNumAffected adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. 10
7
/resultsSection/adverseEventsModule/eventGroups/0/otherNumAtRisk adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. 10
7
/resultsSection/adverseEventsModule/eventGroups/1/title adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. Phase II
Phase Ib: Dose Level 2
/resultsSection/adverseEventsModule/eventGroups/1/description adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. Subjects receive neratinib and capmatinib. The MTD determined during Phase Ib will be used.
Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 200 mg through end of treatment once daily + Capmatinib 400 mg twice daily
/resultsSection/adverseEventsModule/eventGroups/2 adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. {
"id": "EG002",
"title": "Phase Ib: Dose Level 3",
"description": "Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 240 mg through end of treatment once daily + Capmatinib 400 mg twice daily",
"otherNumAtRisk": 0,
"deathsNumAtRisk": 0,
"otherNumAffected": 0,
"seriousNumAtRisk": 0,
"deathsNumAffected": 0,
"seriousNumAffected": 0
} /resultsSection/adverseEventsModule/eventGroups/3 adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. {
"id": "EG003",
"title": "Phase Ib: Dose Level-1",
"description": "Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 300 mg twice daily",
"otherNumAtRisk": 3,
"deathsNumAtRisk": 3,
"otherNumAffected": 3,
"seriousNumAtRisk": 3,
"deathsNumAffected": 1,
"seriousNumAffected": 1
} /resultsSection/adverseEventsModule/eventGroups/4 adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. {
"id": "EG004",
"title": "Phase Ib: Dose Level-2",
"description": "Neratinib 120 mg through end of treatment once daily + Capmatinib 200 mg twice daily",
"otherNumAtRisk": 0,
"deathsNumAtRisk": 0,
"otherNumAffected": 0,
"seriousNumAtRisk": 0,
"deathsNumAffected": 0,
"seriousNumAffected": 0
} /resultsSection/adverseEventsModule/eventGroups/5 adverse_event_group_change Changes to adverse event group-level denominators or affected counts are high review priority. {
"id": "EG005",
"title": "Phase II",
"description": "Subjects receive neratinib and capmatinib.\nThe MTD determined during Phase Ib will be used.",
"otherNumAtRisk": 0,
"deathsNumAtRisk": 0,
"otherNumAffected": 0,
"seriousNumAtRisk": 0,
"deathsNumAffected": 0,
"seriousNumAffected": 0
} /resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numAtRisk serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority. 10
7
/resultsSection/adverseEventsModule/seriousEvents/0/stats/2 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/0/stats/3 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
} /resultsSection/adverseEventsModule/seriousEvents/0/stats/4 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/0/stats/5 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAffected serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority. 1
0
/resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAtRisk serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority. 10
7
/resultsSection/adverseEventsModule/seriousEvents/1/stats/2 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/1/stats/3 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/seriousEvents/1/stats/4 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/1/stats/5 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAffected serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority. 1
0
/resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAtRisk serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority. 10
7
/resultsSection/adverseEventsModule/seriousEvents/2/stats/2 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/2/stats/3 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/seriousEvents/2/stats/4 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/2/stats/5 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAffected serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority. 1
0
/resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAtRisk serious_adverse_event_modification Modification of reported serious adverse event data after results posting is high review priority. 10
7
/resultsSection/adverseEventsModule/seriousEvents/3/stats/2 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/3/stats/3 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/seriousEvents/3/stats/4 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/seriousEvents/3/stats/5 serious_adverse_event_addition Addition of reported serious adverse event data after results posting is high review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/0/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/0/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/0/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
} /resultsSection/adverseEventsModule/otherEvents/0/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/0/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 4
3
/resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/1/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/1/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
} /resultsSection/adverseEventsModule/otherEvents/1/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/1/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/2/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Anorexia
Alkaline Phosphatase Increased
/resultsSection/adverseEventsModule/otherEvents/2/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Metabolism and nutrition disorders
Investigations
/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 4
1
/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/2/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/2/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
} /resultsSection/adverseEventsModule/otherEvents/2/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/2/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/3/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Arthralgia
Anemia
/resultsSection/adverseEventsModule/otherEvents/3/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Musculoskeletal and connective tissue disorders
Blood and lymphatic system disorders
/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 4
1
/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/3/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/3/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/otherEvents/3/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/3/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/4/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Constipation
Anorexia
/resultsSection/adverseEventsModule/otherEvents/4/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Gastrointestinal disorders
Metabolism and nutrition disorders
/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 6
3
/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/4/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/4/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/otherEvents/4/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/4/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/5/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Dehydration
Arthralgia
/resultsSection/adverseEventsModule/otherEvents/5/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Metabolism and nutrition disorders
Musculoskeletal and connective tissue disorders
/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 6
3
/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/5/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/5/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/otherEvents/5/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/5/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/6/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Diarrhea
Aspartate Aminotransferase Increased
/resultsSection/adverseEventsModule/otherEvents/6/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Gastrointestinal disorders
Investigations
/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 8
2
/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/6/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/6/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/otherEvents/6/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/6/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/7/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Dizziness
Back Pain
/resultsSection/adverseEventsModule/otherEvents/7/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Nervous system disorders
Musculoskeletal and connective tissue disorders
/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 6
2
/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/7/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/7/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
} /resultsSection/adverseEventsModule/otherEvents/7/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/7/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/8/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Fatigue
Blood Lactate Dehydrogenase Increased
/resultsSection/adverseEventsModule/otherEvents/8/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. General disorders
Investigations
/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 9
1
/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/8/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/8/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/otherEvents/8/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/8/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/9/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Headache
Cardiac Disorders - Chest tightness
/resultsSection/adverseEventsModule/otherEvents/9/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Nervous system disorders
Cardiac disorders
/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 4
1
/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/9/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/9/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/otherEvents/9/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/9/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/10/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Hypoalbuminemia
Cardiac Troponin T Increased
/resultsSection/adverseEventsModule/otherEvents/10/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Metabolism and nutrition disorders
Investigations
/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 5
0
/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/10/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/10/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
} /resultsSection/adverseEventsModule/otherEvents/10/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/10/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/11/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Myalgia
Constipation
/resultsSection/adverseEventsModule/otherEvents/11/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Musculoskeletal and connective tissue disorders
Gastrointestinal disorders
/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 4
3
/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/11/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/11/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 3
} /resultsSection/adverseEventsModule/otherEvents/11/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/11/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/12/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Nausea
Creatinine Increased
/resultsSection/adverseEventsModule/otherEvents/12/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Gastrointestinal disorders
Investigations
/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 8
3
/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/12/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/12/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
} /resultsSection/adverseEventsModule/otherEvents/12/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/12/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/13/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Platelet Count Decreased
Dehydration
/resultsSection/adverseEventsModule/otherEvents/13/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Investigations
Metabolism and nutrition disorders
/resultsSection/adverseEventsModule/otherEvents/13/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/13/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/13/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
} /resultsSection/adverseEventsModule/otherEvents/13/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/13/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/14/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Serum Amylase Increased
Diarrhea
/resultsSection/adverseEventsModule/otherEvents/14/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Investigations
Gastrointestinal disorders
/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 4
6
/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/14/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/14/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
} /resultsSection/adverseEventsModule/otherEvents/14/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/14/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/15/term other_adverse_event_modification Modification of other adverse event result data is medium review priority. Vomiting
Dizziness
/resultsSection/adverseEventsModule/otherEvents/15/organSystem other_adverse_event_modification Modification of other adverse event result data is medium review priority. Gastrointestinal disorders
Nervous system disorders
/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAffected other_adverse_event_modification Modification of other adverse event result data is medium review priority. 6
3
/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAtRisk other_adverse_event_modification Modification of other adverse event result data is medium review priority. 10
7
/resultsSection/adverseEventsModule/otherEvents/15/stats/2 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG002",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/15/stats/3 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 3
} /resultsSection/adverseEventsModule/otherEvents/15/stats/4 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG004",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/15/stats/5 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"groupId": "EG005",
"numAtRisk": 0
} /resultsSection/adverseEventsModule/otherEvents/16 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Ear and Labyrinth Disorders - Ear drainage",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Ear and labyrinth disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/17 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Edema Limbs",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/18 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Erythema Multiforme",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Skin and subcutaneous tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/19 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Fall",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Injury, poisoning and procedural complications",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/20 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Fatigue",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 6
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 3
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/21 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Flu Like Symptoms",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/22 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Headache",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 3
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Nervous system disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/23 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hematuria",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/24 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hyperglycemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/25 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hyperkalemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/26 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hypoalbuminemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 4
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/27 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hypocalcemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/28 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hypoglycemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/29 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hypokalemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/30 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hypomagnesemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/31 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hyponatremia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/32 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Hypotension",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Vascular disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/33 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Infections and Infestations - Streptococcal pharyngitis",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/34 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Insomnia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Psychiatric disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/35 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Irregular Menstruation",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Reproductive system and breast disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/36 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Localized Edema",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/37 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Lymphocyte Count Decreased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/38 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Mucositis Oral",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Gastrointestinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/39 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Muscle Cramp",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Musculoskeletal and connective tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/40 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Myalgia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 3
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Musculoskeletal and connective tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/41 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Nausea",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 6
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Gastrointestinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/42 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Neutrophil Count Decreased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/43 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Pain",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/44 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Paresthesia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Nervous system disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/45 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Paroxysmal Atrial Tachycardia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Cardiac disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/46 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Platelet Count Decreased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 3
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/47 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Pneumothorax",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Respiratory, thoracic and mediastinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/48 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Productive Cough",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Respiratory, thoracic and mediastinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/49 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Proteinuria",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/50 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Rash Acneiform",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Skin and subcutaneous tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/51 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Serum Amylase Increased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/52 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Shingles",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/53 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Sinus Bradycardia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Cardiac disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/54 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Sinusitis",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/55 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Skin and Subcutaneous Tissue Disorders - Skin lesion",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Skin and subcutaneous tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/56 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Skin Infection",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/57 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Sore Throat",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Respiratory, thoracic and mediastinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/58 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Upper Respiratory Infection",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/59 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Urinary Frequency",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/60 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Urinary Tract Infection",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/61 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Urinary Urgency",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/62 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Urine Discoloration",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/63 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Thromboembolic event",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Vascular disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/64 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Vomiting",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 4
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Gastrointestinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/65 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Watering Eyes",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Eye disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/66 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "Weight Loss",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/otherEvents/67 other_adverse_event_addition Addition of other adverse event result data is medium review priority. {
"term": "White Blood Cell Decreased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
} /resultsSection/adverseEventsModule/armsReviewUnit {
"resetReasons": [
"The arms/groups appear inconsistent with information in other parts of the record. Each arm/group should be described separately, or a valid explanation provided."
]
} /protocolSection/statusModule/statusVerifiedDate 2024-11
2025-02
/protocolSection/statusModule/lastUpdateSubmitDate 2025-01-28
2025-02-24
/resultsSection/participantFlowModule/groups/0/title Phase Ib
Phase Ib: Dose Level 1
/resultsSection/participantFlowModule/groups/0/description Dose Escalation of Neratinib with Capmatinib uses a 3+3 design. Max 18 patients, treated in cohorts of 3, with safety data reviewed after each cohort's DLT period.
Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 400 mg twice daily
/resultsSection/participantFlowModule/groups/1/title Phase II
Phase Ib: Dose Level 2
/resultsSection/participantFlowModule/groups/1/description Subjects receive neratinib and capmatinib. The MTD determined during Phase Ib will be used.
Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 200 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
/resultsSection/participantFlowModule/groups/2 {
"id": "FG002",
"title": "Phase Ib: Dose Level 3",
"description": "Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 240 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
} /resultsSection/participantFlowModule/groups/3 {
"id": "FG003",
"title": "Phase Ib: Dose Level-1",
"description": "Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 300 mg twice daily"
} /resultsSection/participantFlowModule/groups/4 {
"id": "FG004",
"title": "Phase Ib: Dose Level-2",
"description": "Neratinib 120 mg through end of treatment once daily + Capmatinib 200 mg twice daily"
} /resultsSection/participantFlowModule/groups/5 {
"id": "FG005",
"title": "Phase II",
"description": "Subjects receive neratinib and capmatinib.\nThe MTD determined during Phase Ib will be used."
} /resultsSection/participantFlowModule/periods/0/milestones/0/achievements/0/numSubjects 10
7
/resultsSection/participantFlowModule/periods/0/milestones/0/achievements/2 {
"groupId": "FG002",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/milestones/0/achievements/3 {
"groupId": "FG003",
"numSubjects": "3"
} /resultsSection/participantFlowModule/periods/0/milestones/0/achievements/4 {
"groupId": "FG004",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/milestones/0/achievements/5 {
"groupId": "FG005",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/milestones/1/achievements/2 {
"groupId": "FG002",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/milestones/1/achievements/3 {
"groupId": "FG003",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/milestones/1/achievements/4 {
"groupId": "FG004",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/milestones/1/achievements/5 {
"groupId": "FG005",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/milestones/2/achievements/0/numSubjects 10
7
/resultsSection/participantFlowModule/periods/0/milestones/2/achievements/2 {
"groupId": "FG002",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/milestones/2/achievements/3 {
"groupId": "FG003",
"numSubjects": "3"
} /resultsSection/participantFlowModule/periods/0/milestones/2/achievements/4 {
"groupId": "FG004",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/milestones/2/achievements/5 {
"groupId": "FG005",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/0/numSubjects 4
3
/resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/2 {
"groupId": "FG002",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/3 {
"groupId": "FG003",
"numSubjects": "1"
} /resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/4 {
"groupId": "FG004",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/5 {
"groupId": "FG005",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/0/numSubjects 6
4
/resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/2 {
"groupId": "FG002",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/3 {
"groupId": "FG003",
"numSubjects": "2"
} /resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/4 {
"groupId": "FG004",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/5 {
"groupId": "FG005",
"numSubjects": "0"
} /resultsSection/participantFlowModule/periods/0/reviewUnit {
"resetReasons": [
"The participant flow appears to include insufficient information to understand the arms/groups to which participants were assigned, the intervention strategy used in each arm/group, or how participants progressed in the study."
]
} /resultsSection/baselineCharacteristicsModule/groups/0/title Phase Ib
Phase Ib: Dose Level 1
/resultsSection/baselineCharacteristicsModule/groups/0/description Dose Escalation of Neratinib with Capmatinib uses a 3+3 design. Max 18 patients, treated in cohorts of 3, with safety data reviewed after each cohort's DLT period.
Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 400 mg twice daily
/resultsSection/baselineCharacteristicsModule/groups/1/title Phase II
Phase Ib: Dose Level 2
/resultsSection/baselineCharacteristicsModule/groups/1/description Subjects receive neratinib and capmatinib. The MTD determined during Phase Ib will be used.
Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 200 mg through end of treatment once daily + Capmatinib 400 mg twice daily
/resultsSection/baselineCharacteristicsModule/groups/2/title Total
Phase Ib: Dose Level 3
/resultsSection/baselineCharacteristicsModule/groups/2/description Total of all reporting groups
Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 240 mg through end of treatment once daily + Capmatinib 400 mg twice daily
/resultsSection/baselineCharacteristicsModule/groups/3 {
"id": "BG003",
"title": "Phase Ib: Dose Level-1",
"description": "Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 300 mg twice daily"
} /resultsSection/baselineCharacteristicsModule/groups/4 {
"id": "BG004",
"title": "Phase Ib: Dose Level-2",
"description": "Neratinib 120 mg through end of treatment once daily + Capmatinib 200 mg twice daily"
} /resultsSection/baselineCharacteristicsModule/groups/5 {
"id": "BG005",
"title": "Phase II",
"description": "Subjects receive neratinib and capmatinib.\nThe MTD determined during Phase Ib will be used."
} /resultsSection/baselineCharacteristicsModule/groups/6 {
"id": "BG006",
"title": "Total",
"description": "Total of all reporting groups"
} /resultsSection/baselineCharacteristicsModule/denoms/0/counts/0/value 10
7
/resultsSection/baselineCharacteristicsModule/denoms/0/counts/2/value 10
0
/resultsSection/baselineCharacteristicsModule/denoms/0/counts/3 {
"value": "3",
"groupId": "BG003"
} /resultsSection/baselineCharacteristicsModule/denoms/0/counts/4 {
"value": "0",
"groupId": "BG004"
} /resultsSection/baselineCharacteristicsModule/denoms/0/counts/5 {
"value": "0",
"groupId": "BG005"
} /resultsSection/baselineCharacteristicsModule/denoms/0/counts/6 {
"value": "10",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/value 44.5
46
/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/lowerLimit 39
37
/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/upperLimit 62
50
/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/1/value 44.5
39
/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/1/lowerLimit 39
34
/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/2 {
"value": "44.5",
"groupId": "BG006",
"lowerLimit": "39",
"upperLimit": "62"
} /resultsSection/baselineCharacteristicsModule/measures/0/reviewUnit {
"resetReasons": [
"Information within the measure appears inconsistent."
]
} /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/0/value 10
7
/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/1/value 10
3
/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/2 {
"value": "10",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/2 {
"value": "0",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/0/value 2
1
/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/1/value 2
1
/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/2 {
"value": "2",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1/measurements/0/value 8
6
/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1/measurements/1/value 8
2
/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1/measurements/2 {
"value": "8",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/2/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/2/measurements/2 {
"value": "0",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/0/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/0/measurements/2 {
"value": "0",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/1/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/1/measurements/2 {
"value": "0",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/2/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/2/measurements/2 {
"value": "0",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/3/measurements/0/value 4
3
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/3/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/3/measurements/1/value 4
1
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/3/measurements/2 {
"value": "4",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/4/measurements/0/value 5
4
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/4/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/4/measurements/1/value 5
1
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/4/measurements/2 {
"value": "5",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/5/measurements/0/value 1
0
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/5/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/5/measurements/2 {
"value": "1",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/6/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/6/measurements/2 {
"value": "0",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/measures/4/classes/0/categories/0/measurements/0/value 10
7
/resultsSection/baselineCharacteristicsModule/measures/4/classes/0/categories/0/measurements/1/groupId BG002
BG003
/resultsSection/baselineCharacteristicsModule/measures/4/classes/0/categories/0/measurements/1/value 10
3
/resultsSection/baselineCharacteristicsModule/measures/4/classes/0/categories/0/measurements/2 {
"value": "10",
"groupId": "BG006"
} /resultsSection/baselineCharacteristicsModule/reviewUnit {
"resetReasons": [
"The arms/groups appear inconsistent with information in other parts of the record. Each arm/group should be described separately, or a valid explanation provided."
]
} /annotationSection/annotationModule/unpostedAnnotation/unpostedEvents/0/date 2025-02-19
2025-03-11
/reviewUnit {
"resetReasons": [
"Issues noted on a previous submission of this record do not appear to have been addressed."
]
} /resultsSection/outcomeMeasuresModule/outcomeMeasures/0/paramType COUNT_OF_PARTICIPANTS
NUMBER
/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/unitOfMeasure Participants
Dose level (mg)
/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/groups/0/description Dose Escalation of Neratinib with Capmatinib uses a 3+3 design. Max 18 patients, treated in cohorts of 3, with safety data reviewed after each cohort's DLT period.
All participants who received Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 300 mg twice daily or Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 400 mg twice daily
/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/classes/0/categories/0/measurements/0/value 9
NA
/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/classes/0/categories/0/measurements/0/comment No MTD was determined since the study was terminated prematurely during phase Ib.
/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/measureCategoriesReviewUnit {
"resetReasons": [
"The arms/groups appear inconsistent with information in other parts of the record. Each arm/group should be described separately, or a valid explanation provided."
]
} /resultsSection/outcomeMeasuresModule/outcomeMeasures/0/populationDescription Baseline analysis population included all participants treated.
[
{
"op": "replace",
"path": "/protocolSection/statusModule/statusVerifiedDate",
"value": "2025-02"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdateSubmitDate",
"value": "2025-02-24"
},
{
"op": "replace",
"path": "/resultsSection/participantFlowModule/groups/0/title",
"value": "Phase Ib: Dose Level 1"
},
{
"op": "replace",
"path": "/resultsSection/participantFlowModule/groups/0/description",
"value": "Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
},
{
"op": "replace",
"path": "/resultsSection/participantFlowModule/groups/1/title",
"value": "Phase Ib: Dose Level 2"
},
{
"op": "replace",
"path": "/resultsSection/participantFlowModule/groups/1/description",
"value": "Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 200 mg through end of treatment once daily + Capmatinib 400 mg twice daily""
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/groups/2",
"value": {
"id": "FG002",
"title": "Phase Ib: Dose Level 3",
"description": "Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 240 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/groups/3",
"value": {
"id": "FG003",
"title": "Phase Ib: Dose Level-1",
"description": "Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 300 mg twice daily"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/groups/4",
"value": {
"id": "FG004",
"title": "Phase Ib: Dose Level-2",
"description": "Neratinib 120 mg through end of treatment once daily + Capmatinib 200 mg twice daily"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/groups/5",
"value": {
"id": "FG005",
"title": "Phase II",
"description": "Subjects receive neratinib and capmatinib.\nThe MTD determined during Phase Ib will be used."
}
},
{
"op": "replace",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/0/achievements/0/numSubjects",
"value": "7"
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/0/achievements/2",
"value": {
"groupId": "FG002",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/0/achievements/3",
"value": {
"groupId": "FG003",
"numSubjects": "3"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/0/achievements/4",
"value": {
"groupId": "FG004",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/0/achievements/5",
"value": {
"groupId": "FG005",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/1/achievements/2",
"value": {
"groupId": "FG002",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/1/achievements/3",
"value": {
"groupId": "FG003",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/1/achievements/4",
"value": {
"groupId": "FG004",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/1/achievements/5",
"value": {
"groupId": "FG005",
"numSubjects": "0"
}
},
{
"op": "replace",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/2/achievements/0/numSubjects",
"value": "7"
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/2/achievements/2",
"value": {
"groupId": "FG002",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/2/achievements/3",
"value": {
"groupId": "FG003",
"numSubjects": "3"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/2/achievements/4",
"value": {
"groupId": "FG004",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/milestones/2/achievements/5",
"value": {
"groupId": "FG005",
"numSubjects": "0"
}
},
{
"op": "replace",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/0/numSubjects",
"value": "3"
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/2",
"value": {
"groupId": "FG002",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/3",
"value": {
"groupId": "FG003",
"numSubjects": "1"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/4",
"value": {
"groupId": "FG004",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/0/reasons/5",
"value": {
"groupId": "FG005",
"numSubjects": "0"
}
},
{
"op": "replace",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/0/numSubjects",
"value": "4"
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/2",
"value": {
"groupId": "FG002",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/3",
"value": {
"groupId": "FG003",
"numSubjects": "2"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/4",
"value": {
"groupId": "FG004",
"numSubjects": "0"
}
},
{
"op": "add",
"path": "/resultsSection/participantFlowModule/periods/0/dropWithdraws/1/reasons/5",
"value": {
"groupId": "FG005",
"numSubjects": "0"
}
},
{
"op": "remove",
"path": "/resultsSection/participantFlowModule/periods/0/reviewUnit"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/groups/0/title",
"value": "Phase Ib: Dose Level 1"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/groups/0/description",
"value": "Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/groups/1/title",
"value": "Phase Ib: Dose Level 2"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/groups/1/description",
"value": "Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 200 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/groups/2/title",
"value": "Phase Ib: Dose Level 3"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/groups/2/description",
"value": "Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 240 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/groups/3",
"value": {
"id": "BG003",
"title": "Phase Ib: Dose Level-1",
"description": "Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 300 mg twice daily"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/groups/4",
"value": {
"id": "BG004",
"title": "Phase Ib: Dose Level-2",
"description": "Neratinib 120 mg through end of treatment once daily + Capmatinib 200 mg twice daily"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/groups/5",
"value": {
"id": "BG005",
"title": "Phase II",
"description": "Subjects receive neratinib and capmatinib.\nThe MTD determined during Phase Ib will be used."
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/groups/6",
"value": {
"id": "BG006",
"title": "Total",
"description": "Total of all reporting groups"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/0/value",
"value": "7"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/2/value",
"value": "0"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/3",
"value": {
"value": "3",
"groupId": "BG003"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/4",
"value": {
"value": "0",
"groupId": "BG004"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/5",
"value": {
"value": "0",
"groupId": "BG005"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/denoms/0/counts/6",
"value": {
"value": "10",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/value",
"value": "46"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/lowerLimit",
"value": "37"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/0/upperLimit",
"value": "50"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/1/groupId",
"value": "BG003"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/1/value",
"value": "39"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/1/lowerLimit",
"value": "34"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/classes/0/categories/0/measurements/2",
"value": {
"value": "44.5",
"groupId": "BG006",
"lowerLimit": "39",
"upperLimit": "62"
}
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/0/reviewUnit",
"value": {
"resetReasons": [
"Information within the measure appears inconsistent."
]
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/0/value",
"value": "7"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/1/groupId",
"value": "BG003"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/1/value",
"value": "3"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/0/measurements/2",
"value": {
"value": "10",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/1/groupId",
"value": "BG003"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/1/classes/0/categories/1/measurements/2",
"value": {
"value": "0",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/0/value",
"value": "1"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/1/groupId",
"value": "BG003"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/1/value",
"value": "1"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/0/measurements/2",
"value": {
"value": "2",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1/measurements/0/value",
"value": "6"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1/measurements/1/groupId",
"value": "BG003"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1/measurements/1/value",
"value": "2"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/1/measurements/2",
"value": {
"value": "8",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/2/measurements/1/groupId",
"value": "BG003"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/2/classes/0/categories/2/measurements/2",
"value": {
"value": "0",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/0/measurements/1/groupId",
"value": "BG003"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/0/measurements/2",
"value": {
"value": "0",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/1/measurements/1/groupId",
"value": "BG003"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/1/measurements/2",
"value": {
"value": "0",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/2/measurements/1/groupId",
"value": "BG003"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/2/measurements/2",
"value": {
"value": "0",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/3/measurements/0/value",
"value": "3"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/3/measurements/1/groupId",
"value": "BG003"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/3/measurements/1/value",
"value": "1"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/3/measurements/2",
"value": {
"value": "4",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/4/measurements/0/value",
"value": "4"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/4/measurements/1/groupId",
"value": "BG003"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/4/measurements/1/value",
"value": "1"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/4/measurements/2",
"value": {
"value": "5",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/5/measurements/0/value",
"value": "0"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/5/measurements/1/groupId",
"value": "BG003"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/5/measurements/2",
"value": {
"value": "1",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/6/measurements/1/groupId",
"value": "BG003"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/3/classes/0/categories/6/measurements/2",
"value": {
"value": "0",
"groupId": "BG006"
}
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/4/classes/0/categories/0/measurements/0/value",
"value": "7"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/4/classes/0/categories/0/measurements/1/groupId",
"value": "BG003"
},
{
"op": "replace",
"path": "/resultsSection/baselineCharacteristicsModule/measures/4/classes/0/categories/0/measurements/1/value",
"value": "3"
},
{
"op": "add",
"path": "/resultsSection/baselineCharacteristicsModule/measures/4/classes/0/categories/0/measurements/2",
"value": {
"value": "10",
"groupId": "BG006"
}
},
{
"op": "remove",
"path": "/resultsSection/baselineCharacteristicsModule/reviewUnit"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/paramType",
"value": "NUMBER"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/unitOfMeasure",
"value": "Dose level (mg)"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/groups/0/description",
"value": "All participants who received Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 300 mg twice daily or Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
},
{
"op": "replace",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/classes/0/categories/0/measurements/0/value",
"value": "NA"
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/classes/0/categories/0/measurements/0/comment",
"value": "No MTD was determined since the study was terminated prematurely during phase Ib."
},
{
"op": "remove",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/measureCategoriesReviewUnit"
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/0/populationDescription",
"value": "Baseline analysis population included all participants treated."
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/frequencyThreshold",
"value": "0"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/title",
"value": "Phase Ib: Dose Level 1"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/description",
"value": "Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/deathsNumAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/deathsNumAtRisk",
"value": 7
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/seriousNumAffected",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/seriousNumAtRisk",
"value": 7
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/otherNumAffected",
"value": 7
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/0/otherNumAtRisk",
"value": 7
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/1/title",
"value": "Phase Ib: Dose Level 2"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/eventGroups/1/description",
"value": "Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 200 mg through end of treatment once daily + Capmatinib 400 mg twice daily"
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/eventGroups/2",
"value": {
"id": "EG002",
"title": "Phase Ib: Dose Level 3",
"description": "Neratinib 120 mg Dose 1-7, 160 mg Dose 8-14, 240 mg through end of treatment once daily + Capmatinib 400 mg twice daily",
"otherNumAtRisk": 0,
"deathsNumAtRisk": 0,
"otherNumAffected": 0,
"seriousNumAtRisk": 0,
"deathsNumAffected": 0,
"seriousNumAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/eventGroups/3",
"value": {
"id": "EG003",
"title": "Phase Ib: Dose Level-1",
"description": "Neratinib 120 mg Dose 1-7, 160 mg through end of treatment once daily + Capmatinib 300 mg twice daily",
"otherNumAtRisk": 3,
"deathsNumAtRisk": 3,
"otherNumAffected": 3,
"seriousNumAtRisk": 3,
"deathsNumAffected": 1,
"seriousNumAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/eventGroups/4",
"value": {
"id": "EG004",
"title": "Phase Ib: Dose Level-2",
"description": "Neratinib 120 mg through end of treatment once daily + Capmatinib 200 mg twice daily",
"otherNumAtRisk": 0,
"deathsNumAtRisk": 0,
"otherNumAffected": 0,
"seriousNumAtRisk": 0,
"deathsNumAffected": 0,
"seriousNumAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/eventGroups/5",
"value": {
"id": "EG005",
"title": "Phase II",
"description": "Subjects receive neratinib and capmatinib.\nThe MTD determined during Phase Ib will be used.",
"otherNumAtRisk": 0,
"deathsNumAtRisk": 0,
"otherNumAffected": 0,
"seriousNumAtRisk": 0,
"deathsNumAffected": 0,
"seriousNumAffected": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/0/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/1/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/2/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/seriousEvents/3/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/0/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAffected",
"value": 3
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/1/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/term",
"value": "Alkaline Phosphatase Increased"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/organSystem",
"value": "Investigations"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAffected",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/2/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/term",
"value": "Anemia"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/organSystem",
"value": "Blood and lymphatic system disorders"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAffected",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/3/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/term",
"value": "Anorexia"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/organSystem",
"value": "Metabolism and nutrition disorders"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAffected",
"value": 3
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/4/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/term",
"value": "Arthralgia"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/organSystem",
"value": "Musculoskeletal and connective tissue disorders"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAffected",
"value": 3
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/5/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/term",
"value": "Aspartate Aminotransferase Increased"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/organSystem",
"value": "Investigations"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAffected",
"value": 2
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/6/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/term",
"value": "Back Pain"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/organSystem",
"value": "Musculoskeletal and connective tissue disorders"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAffected",
"value": 2
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/7/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/term",
"value": "Blood Lactate Dehydrogenase Increased"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/organSystem",
"value": "Investigations"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAffected",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/8/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/term",
"value": "Cardiac Disorders - Chest tightness"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/organSystem",
"value": "Cardiac disorders"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAffected",
"value": 1
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/9/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/term",
"value": "Cardiac Troponin T Increased"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/organSystem",
"value": "Investigations"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAffected",
"value": 0
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/10/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/term",
"value": "Constipation"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/organSystem",
"value": "Gastrointestinal disorders"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAffected",
"value": 3
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 3
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/11/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/term",
"value": "Creatinine Increased"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/organSystem",
"value": "Investigations"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAffected",
"value": 3
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/12/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/term",
"value": "Dehydration"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/organSystem",
"value": "Metabolism and nutrition disorders"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/13/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/term",
"value": "Diarrhea"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/organSystem",
"value": "Gastrointestinal disorders"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAffected",
"value": 6
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/14/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/term",
"value": "Dizziness"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/organSystem",
"value": "Nervous system disorders"
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAffected",
"value": 3
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/0/numAtRisk",
"value": 7
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/2",
"value": {
"groupId": "EG002",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/3",
"value": {
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 3
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/4",
"value": {
"groupId": "EG004",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/15/stats/5",
"value": {
"groupId": "EG005",
"numAtRisk": 0
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/16",
"value": {
"term": "Ear and Labyrinth Disorders - Ear drainage",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Ear and labyrinth disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/17",
"value": {
"term": "Edema Limbs",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/18",
"value": {
"term": "Erythema Multiforme",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Skin and subcutaneous tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/19",
"value": {
"term": "Fall",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Injury, poisoning and procedural complications",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/20",
"value": {
"term": "Fatigue",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 6
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 3
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/21",
"value": {
"term": "Flu Like Symptoms",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/22",
"value": {
"term": "Headache",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 3
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Nervous system disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/23",
"value": {
"term": "Hematuria",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/24",
"value": {
"term": "Hyperglycemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/25",
"value": {
"term": "Hyperkalemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/26",
"value": {
"term": "Hypoalbuminemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 4
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/27",
"value": {
"term": "Hypocalcemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/28",
"value": {
"term": "Hypoglycemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/29",
"value": {
"term": "Hypokalemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/30",
"value": {
"term": "Hypomagnesemia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/31",
"value": {
"term": "Hyponatremia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Metabolism and nutrition disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/32",
"value": {
"term": "Hypotension",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Vascular disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/33",
"value": {
"term": "Infections and Infestations - Streptococcal pharyngitis",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/34",
"value": {
"term": "Insomnia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Psychiatric disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/35",
"value": {
"term": "Irregular Menstruation",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Reproductive system and breast disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/36",
"value": {
"term": "Localized Edema",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/37",
"value": {
"term": "Lymphocyte Count Decreased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/38",
"value": {
"term": "Mucositis Oral",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Gastrointestinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/39",
"value": {
"term": "Muscle Cramp",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Musculoskeletal and connective tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/40",
"value": {
"term": "Myalgia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 3
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Musculoskeletal and connective tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/41",
"value": {
"term": "Nausea",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 6
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Gastrointestinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/42",
"value": {
"term": "Neutrophil Count Decreased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/43",
"value": {
"term": "Pain",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "General disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/44",
"value": {
"term": "Paresthesia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Nervous system disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/45",
"value": {
"term": "Paroxysmal Atrial Tachycardia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Cardiac disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/46",
"value": {
"term": "Platelet Count Decreased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 3
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/47",
"value": {
"term": "Pneumothorax",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Respiratory, thoracic and mediastinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/48",
"value": {
"term": "Productive Cough",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Respiratory, thoracic and mediastinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/49",
"value": {
"term": "Proteinuria",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/50",
"value": {
"term": "Rash Acneiform",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Skin and subcutaneous tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/51",
"value": {
"term": "Serum Amylase Increased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/52",
"value": {
"term": "Shingles",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/53",
"value": {
"term": "Sinus Bradycardia",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Cardiac disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/54",
"value": {
"term": "Sinusitis",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/55",
"value": {
"term": "Skin and Subcutaneous Tissue Disorders - Skin lesion",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Skin and subcutaneous tissue disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/56",
"value": {
"term": "Skin Infection",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/57",
"value": {
"term": "Sore Throat",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Respiratory, thoracic and mediastinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/58",
"value": {
"term": "Upper Respiratory Infection",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/59",
"value": {
"term": "Urinary Frequency",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/60",
"value": {
"term": "Urinary Tract Infection",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Infections and infestations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/61",
"value": {
"term": "Urinary Urgency",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/62",
"value": {
"term": "Urine Discoloration",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Renal and urinary disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/63",
"value": {
"term": "Thromboembolic event",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Vascular disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/64",
"value": {
"term": "Vomiting",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 4
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 2
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Gastrointestinal disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/65",
"value": {
"term": "Watering Eyes",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 1
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Eye disorders",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/66",
"value": {
"term": "Weight Loss",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 2
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 0
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "add",
"path": "/resultsSection/adverseEventsModule/otherEvents/67",
"value": {
"term": "White Blood Cell Decreased",
"stats": [
{
"groupId": "EG000",
"numAtRisk": 7,
"numAffected": 0
},
{
"groupId": "EG001",
"numAtRisk": 0
},
{
"groupId": "EG002",
"numAtRisk": 0
},
{
"groupId": "EG003",
"numAtRisk": 3,
"numAffected": 1
},
{
"groupId": "EG004",
"numAtRisk": 0
},
{
"groupId": "EG005",
"numAtRisk": 0
}
],
"organSystem": "Investigations",
"assessmentType": "NON_SYSTEMATIC_ASSESSMENT"
}
},
{
"op": "remove",
"path": "/resultsSection/adverseEventsModule/armsReviewUnit"
},
{
"op": "replace",
"path": "/annotationSection/annotationModule/unpostedAnnotation/unpostedEvents/0/date",
"value": "2025-03-11"
},
{
"op": "add",
"path": "/reviewUnit",
"value": {
"resetReasons": [
"Issues noted on a previous submission of this record do not appear to have been addressed."
]
}
}
]